Back to MORGAN STANLEY

RPRX
8 quarters

Position history for MORGAN STANLEY's holdings in ROYALTY PHARMA PLC

MORGAN STANLEY holds 43.6M shares of RPRX (ROYALTY PHARMA PLC), worth $2.1B as of 2026-Q1. The position was decreased (-21.2% shares). RPRX represents 0.1% of MORGAN STANLEY's portfolio.

Current Value

$2.1B

Current Shares

43.6M

Total Value Change

+$926.3M

Total Shares Change

-561,813

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Decreased
43.6M
-21.2%
$2.1B0.1%$47.48
0
2025-Q4
Increased
55.3M
+25.2%
$2.1B0.1%$38.99
47
2025-Q3
Decreased
44.2M
-5.2%
$1.6B0.1%$35.05
0
2025-Q2
Increased
46.6M
+13.6%
$1.7B0.1%$35.46
43
2025-Q1
Increased
41M
+3.8%
$1.3B0.1%$30.80
33
2024-Q4
Decreased
39.5M
-3.8%
$1B0.1%$24.70
0
2024-Q3
Decreased
41.1M
-6.9%
$1.2B0.1%$27.29
0
2024-Q2
New
44.1M
-
$1.2B0.1%$25.32
44

Other major holders of RPRX: ADAGE CAPITAL PARTNERS GP, L.L.C., Capital International Investors, FMR LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used